[1]
Nazir, M. et al. 2025. Interleukin-17 and myeloperoxidase levels in patients with non-alcoholic fatty liver disease and effect of disease severity on blood counts and liver enzymes. KHYBER MEDICAL UNIVERSITY JOURNAL. 17, 1 (Mar. 2025), 71–6. DOI:https://doi.org/10.35845/kmuj.2025.23728.